We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Pauses PTAB Review Of Restasis Patents

Law360 (March 28, 2018, 7:21 PM EDT) -- The Federal Circuit on Wednesday ordered the Patent Trial and Appeal Board to pause its review of patents covering Allergan PLC’s dry eye medication Restasis while the appeals court considers arguments...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 5, 2018

Law Firms

Companies

Government Agencies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.